中国侵入式脑机接口技术连续造福患者的背后：抱以希望、审慎看待

Core Insights - The Chinese scientific team has conducted two additional clinical trials of invasive brain-machine interface (BMI) technology since the first trial began in March, providing hope for patients [1][3]. Group 1: Clinical Trials and Technology Development - The invasive BMI technology is still in its early clinical trial stages, with significant advancements needed for practical applications [3]. - A middle-aged patient with high-level paraplegia was able to control a smart wheelchair and a robotic dog using thoughts, showcasing the potential of BMI technology [5]. - The research team is employing techniques such as neural data compression and delay optimization to enhance the efficiency of information transfer from the brain to external devices [5]. Group 2: Future Applications and Ethical Considerations - The team aims to improve control levels and expand the range of devices that can be operated through BMI technology, including humanoid robots [5]. - Ethical considerations surrounding the use of BMI technology, including its application for medical purposes versus cognitive enhancement, are being discussed within the industry [3]. - The research team is focused on making the technology not only advanced but also practical and affordable for a wider range of patients [5].